HPIS built a detailed model with plant & personnel expansion scenarios; the model included an item-by-item income statement forecast and consolidation of 2 corporate entities through merger following acquisition. We also conducted an in-depth study of the pharmaceuticals supply chain including drug manufacturing, distribution, packaging, payment sources, and retail pharmacies and identified avenues for growth post-acquisition. Our materials were used to raise senior debt, mezzanine, and equity capital for the transaction.

For this acquisition of a supplier to Tier 1 and Tier 2 automotive customers HPIS conducted an in-depth study of the automotive market and demand for plastic components and parts, modeled operations and financial performance with several item-by-item sales forecast scenarios tied to capital expenditures on plant capacity and expansion of the product line. Our materials were used to raise senior debt and equity capital for the transaction.